ZA78421B - New vaccine - Google Patents

New vaccine

Info

Publication number
ZA78421B
ZA78421B ZA00780421A ZA78421A ZA78421B ZA 78421 B ZA78421 B ZA 78421B ZA 00780421 A ZA00780421 A ZA 00780421A ZA 78421 A ZA78421 A ZA 78421A ZA 78421 B ZA78421 B ZA 78421B
Authority
ZA
South Africa
Prior art keywords
new vaccine
vaccine
new
Prior art date
Application number
ZA00780421A
Other languages
English (en)
Inventor
G Bijlenga
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of ZA78421B publication Critical patent/ZA78421B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
ZA00780421A 1977-01-26 1978-01-24 New vaccine ZA78421B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3258/77A GB1596653A (en) 1977-01-26 1977-01-26 Vaccine

Publications (1)

Publication Number Publication Date
ZA78421B true ZA78421B (en) 1979-01-31

Family

ID=9754946

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00780421A ZA78421B (en) 1977-01-26 1978-01-24 New vaccine

Country Status (20)

Country Link
US (2) US4320115A (de)
JP (2) JPS5394084A (de)
AT (1) AT368005B (de)
BE (1) BE863368A (de)
CA (1) CA1112167A (de)
CH (2) CH659084A5 (de)
DE (1) DE2803240B2 (de)
DK (1) DK36378A (de)
ES (2) ES466359A1 (de)
FI (1) FI59812C (de)
FR (1) FR2378859B1 (de)
GB (1) GB1596653A (de)
IE (1) IE46498B1 (de)
IT (1) IT1192756B (de)
LU (1) LU78951A1 (de)
NL (1) NL174371C (de)
NO (1) NO780156L (de)
PT (1) PT67554B (de)
SE (2) SE444453B (de)
ZA (1) ZA78421B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
EP0100752A3 (de) * 1982-08-04 1985-04-17 Veterinär-Bakteriologisches Institut der Universität Bern Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
CA1249518A (en) * 1985-09-06 1989-01-31 David Johnston Oral immunization of mammals
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
AU2359195A (en) * 1994-04-19 1995-11-10 Thomas Jefferson University Viral ribonucleocapsid as an immunological enhancer
US6495360B1 (en) * 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
US20030118628A1 (en) * 2001-04-05 2003-06-26 Tutuncu Nurhan Pinar Confectionery product having a salivation region and an oral comfort region
CN112342185B (zh) * 2020-11-11 2022-12-02 深圳市卫光生物制品股份有限公司 一种鸡胚细胞狂犬病病毒的生物反应器工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1015262A (en) * 1962-02-09 1965-12-31 Nat Res Dev Virus culture
US3255080A (en) * 1962-08-06 1966-06-07 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
FR1567869A (de) * 1967-06-22 1969-05-23
US4014991A (en) * 1976-01-23 1977-03-29 The United States Of America As Represented By The Department Of Health, Education And Welfare Oral rabies immunization of carnivores

Also Published As

Publication number Publication date
CH659084A5 (de) 1986-12-31
LU78951A1 (fr) 1979-09-06
NO780156L (no) 1978-07-27
JPS6225127B2 (de) 1987-06-01
NL174371C (nl) 1984-06-01
IT7867143A0 (it) 1978-01-25
ATA52678A (de) 1982-01-15
PT67554A (en) 1978-02-01
ES466359A1 (es) 1978-10-01
FI59812B (fi) 1981-06-30
SE7800781L (sv) 1978-07-27
AT368005B (de) 1982-08-25
DE2803240B2 (de) 1980-08-07
IE780161L (en) 1978-07-26
CH658192A5 (de) 1986-10-31
JPS5394084A (en) 1978-08-17
SE443924B (sv) 1986-03-17
US4400472A (en) 1983-08-23
DK36378A (da) 1978-07-27
US4320115A (en) 1982-03-16
FI780184A (fi) 1978-07-27
FI59812C (fi) 1981-10-12
BE863368A (fr) 1978-07-26
PT67554B (en) 1979-06-18
ES469937A1 (es) 1978-12-16
SE444453B (sv) 1986-04-14
FR2378859B1 (de) 1980-08-29
NL7800708A (nl) 1978-07-28
IE46498B1 (en) 1983-06-29
GB1596653A (en) 1981-08-26
DE2803240A1 (de) 1978-08-10
SE8201768L (sv) 1982-03-19
JPS5877822A (ja) 1983-05-11
IT1192756B (it) 1988-05-04
FR2378859A1 (de) 1978-08-25
CA1112167A (en) 1981-11-10
JPS637754B2 (de) 1988-02-18

Similar Documents

Publication Publication Date Title
GB2009771B (en) Vaccine
AU4201478A (en) Step-stools
ZA782086B (en) Anthelmintica
JPS53112843A (en) New 44acylaminoophenyllethanollamine
ZA78757B (en) Respiratory sybcytial vaccine
AU3728978A (en) Sulfamoyl-aryl-ketones
AU3526278A (en) L-sucrose
GB2001530B (en) Vaccine
GB2001851B (en) Vaccine preparations
ZA78421B (en) New vaccine
AU4022878A (en) Thiopropionamides
AU3677378A (en) N-acylmethyl-chloroacetanilides
AU3828478A (en) Benzodiazepine-diones
AU3797378A (en) Paramyxovirus vaccine
HK32783A (en) New phenylazacycloalkanes
AU3785078A (en) Piperidino-propanols
AU3918778A (en) Beta-substituted-diketones
JPS5480408A (en) Comosite vaccine
GB2010833B (en) Homoerburnamine preparation
AU3939078A (en) 2-chlorosulfinylazetidin-4-ones
AU3355078A (en) Aryl-hexafuranosides
AU4026278A (en) Thienobenzazepines
AU3939978A (en) 2-guanidinomethyl-indoline
AU3774978A (en) Butyl-p-benzoylbenzoates
AU3533578A (en) Micro-mill-mixer